VivoPower completes filing of 2024 Annual Report on Form 20-F
Filing follows successful completion of the independent audit for the year ended 30 June 2024 Prior non-compliance with NASDAQ listing […]
Silvaco Announces that The Ninth Circuit affirmed the dismissal of all claims against Silvaco brought by Aldini AG
SANTA CLARA, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco”), a provider of TCAD, EDA software […]
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on […]
ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing […]
Preferred Bank Announces Additional Q4 Expense
LOS ANGELES, Dec. 19, 2024 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), (“the Bank”), an independent commercial bank, today announced […]
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDerm Cohealyx expected to triple AVITA Medical’s addressable […]
Xcel Brands to Host Third Quarter 2024 Earnings Call on December 23, 2024
NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), today announced that it […]
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at […]
VCI Global Embarks on a Strategic Series of Renewable Energy Asset Acquisitions, Starting with a North Macedonia Solar Farm
KUALA LUMPUR, Malaysia, Dec. 19, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), has […]
Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye
ALPHARETTA, Ga., Dec. 19, 2024 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies […]
